Collagen supply agreement to Yucel Medical

Collagen Solutions Plc

(the "Company" or the "Group")

Supply Agreement with Yucel

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that its subsidiary Collagen Solutions Inc. has signed a supply agreement with Turkish medical device company Yücel Medikal Ltd (Yucel)

This supply agreement covers the provision of collagen materials and support services for use in Yucel's product Lyocoll which is currently on sale in Turkey. Lyocoll is a local haemostatic used in all types of surgery to control capillary and venous bleeding as well as oozing where the conventional methods are impractical and ineffective.

Commenting on the agreement Dr Stewart White, CEO of Collagen Solutions, said: "Collagen Solutions is pleased to have signed another supply agreement with our valued customer Yucel to provide materials for their haemostatic product Lyocoll. This supply agreement further demonstrates the range of products that our medical grade collagens are suitable for and the global nature of our reach."

Senol Yucel, CEO of Yucel added: "Consistency of product and continuity of supply are two very important factors for us and we have carried out a thorough review of the capabilities of Collagen Solutions to deliver the specific collagen that we require for Lyocoll. We are therefore pleased to be able to sign this agreement with a company which we can trust to deliver a quality product for us."

Enquiries: